Background: We examined temporal trends in deaths mentioning both pancreatic cancer and renal failure in the United States. Methods: We analyzed CDC WONDER multiple-cause-of-death data for adults aged ≥25 years from 1999 to 2024. Age-adjusted mortality rates (AAMRs) were assessed using Joinpoint regression. Secondary a...
A. Dhali, Ali Shan Hafeez, J. Biswas et al.· Epidemiologia· 0 citations
Findings should be interpreted as hypothesis-generating rather than definitive evidence of superiority or equivalence, but larger, prospective, multi-centre studies with standardised outcome definitions and robust adjustment for confounding are needed to clarify the comparative clinical and cost-effectiveness of roboti...
H. Bharadwaj, E. Danda, S. H. Ali et al.· Medical Science· 0 citations
This review synthesizes evidence from landmark trials, molecular biomarker analyses, and real-world cohort studies to propose a practical risk-adapted algorithm integrating tumor biology, molecular co-alterations, patient performance status, comorbidities, logistical feasibility, and treatment preference that may deriv...
Ashish Sharma, J. Tan, Harendra Kumar et al.· Medical Oncology· 0 citations
A narrative review synthesizes evidence published between 2020 and 2026 within a unified clinical framework not provided by prior reviews, and proposes an original biomarker-guided clinical algorithm, a comparative clinical readiness table, and a disease-continuum biomarker timeline as practical tools for clinicians an...
Ashish Sharma, J. Tan, Rajvardhan Sisodia et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
